Reuters logo
BRIEF-Karyopharm appoints Michael Falvey as CFO, adds new clinical strategy
September 12, 2017 / 8:09 PM / 2 months ago

BRIEF-Karyopharm appoints Michael Falvey as CFO, adds new clinical strategy

Sept 12 (Reuters) - Karyopharm Therapeutics Inc

* Karyopharm appoints Michael Falvey as chief financial officer, adds new clinical strategy and human resources executives and reports inducement grant under NASDAQ listing rule 5635(c)(4)

* Says Michael Falvey appointed CFO Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below